期刊文献+

芪参益气滴丸治疗糖尿病心脏病合并心功能不全的临床研究 被引量:12

Clinical research on treating diabetes heart disease with heart failure with Qishen Yiqi pills
下载PDF
导出
摘要 目的:观察芪参益气滴丸(天津天士力制药股份有限公司生产)对糖尿病性心脏病合并心功能不全的治疗作用。方法:选择入住我院的2012-2013年糖尿病性心脏病合并心功能不全患者88例,随机分成常规治疗组(对照组)和芪参益气滴丸组(治疗组),对照组给予降糖、降脂,强心、利尿、扩血管、抑制心肌重构等抗心衰治疗,治疗组在对照组基础上给予口服芪参益气滴丸,服药时间3个月,分别于服药前及服药后3个月后检查血脂、血糖、C反应蛋白、心钠素(BNP)及心脏超声,左室舒张末期内径(LVDd)、左室舒张末期容积(LVEDV)、左室收缩末期容积(LVESV)左室射血分数(LVEF)结果:经3个月治疗后,芪参益气滴丸治疗组LVDd、LVEDV、LVESV较对照组减低,差异显著(P<0.05),血浆BNP水平较对照组降低(P<0.05),左室射血分数明显提高(P<0.05),C反应蛋白水平明显降低。结论:在常规治疗的基础上加用芪参益气滴丸治疗糖尿病性心脏病合并心功能不全,能改善整体左室功能,具有一定的抗心室重构作用。能明显降低血浆BNP的水平,更好地改善心脏功能。 Objective: To observe the effect of Qishen Yiqi drop pills (Tianjin Tasly pharmaceutical Limited by Share Ltd) on treating diabetes heart disease with heart failure. Methods:From 2012 to 2013, 78 patients with diabetes heart disease with heart failure in our hospital were randomly divided into conventional treatment group (control group) and Qishen Yiqi pills group (treated group), the control group was given hypoglycemic, lipid-lowering, strong heart, diuretic, vasodilator, inhibiting myocardial reconstruction and other anti heart failure treatment, the treated group was given oral Qishen Yiqi pills more, taking time for 3 months, respectively before treatment and after treatment for 3 months after the blood fat, blood sugar, C reactive protein, atrial natriuretic peptide (BNP) and echocardiography, left ventricular end diastolic diameter (LVDd), left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV) and left ventricular ejection fraction (LVEF). Results: After 3 months after treatment, Qishen Yiqi pills group LVDd, LVEDV, LVESV lower than the control group, the difference was significant (P〈0.05), the plasma BNP level was lower than control group (P〈0.05), LVEF was significantly increased (P〈0.05), C reactive protein level decreased significantly. Conclusion:On the basis of conventional therapy plus Qishen Yiqi drop pills for treating diabetic heart with heart failure, can improve left ventricular function, has certain effect of anti-ventricular remodeling, can obviously decrease level of plasma BNP, improve heart function.
作者 冉秀荣
出处 《中医临床研究》 2014年第5期1-2,共2页 Clinical Journal Of Chinese Medicine
关键词 芪参益气滴丸 糖尿病性心脏病 心功能不全 Qishen Yiqi pills Diabetes heart disease Heart failure
  • 相关文献

参考文献6

二级参考文献27

  • 1耿庆信,朱兴雷,张兴华,朱梅,唐元升,吕晓霞,韩冰.参麦注射液及复方丹参注射液合用对急性心肌梗死患者介入治疗后再灌注损伤的影响[J].中国中西医结合杂志,2004,24(6):496-499. 被引量:25
  • 2英明中,李小鹰,孙存普,吴可,丛建波,汪德清.黄芪总黄酮对大鼠心肌缺血-再灌注自由基的影响[J].中国中药杂志,1996,21(5):304-305. 被引量:53
  • 3陈可冀.迈向21世纪的中西医结合[M].北京:中国医药科技出版社,1991.207.
  • 4李连达 张荣利.双龙方与自体骨髓单个核细胞经心导管移植对中国小型猪心肌梗死的治疗作用研究[A]..第二届中日韩血瘀证及活血化瘀研究学术大会[G].北京:中国中西医结合学会,2003.39-47.
  • 5Suematsu Makoto. Microvascular aspects of gas biology korea congress on the blood stasis syndrome [J ]. Article Collection,2003:4-5.
  • 6Kenner M D, Zajac E J, Kondos G T, et al. Ability of the no - reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one - month follow - up[J]. Am J Cardiol,1995,76 : 861 - 868.
  • 7Reanic F S, Wainstein M, Lee M K Y, et al. NO - reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[ J ]. Am Heart J, 2003,145 : 42 - 46.
  • 8Abbo K M, Dooris M, Glazier S, et al. Feature and outcome of NOO- reflow after percutaneous coronary intervention [ J ]. Am J Cardiol, 1995,75 : 778 - 782.
  • 9Rezkalla S H, Kloner R A. No- reflow phenomenon[J]. Circulation,2002,105 : 656.
  • 10Jia Haizhong, Shi Zaixiang, Ke Yuannan. Clinical observation on antiruisi presrintion in preventing restenosis after coronary stemting[J]. Chinese Kpirmal of Integrative Medicine, 2004,10(2):141 -143.

共引文献84

同被引文献156

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部